Literature DB >> 21073449

Validity of The Health Improvement Network (THIN) for the study of psoriasis.

N M Seminara1, K Abuabara, D B Shin, S M Langan, S E Kimmel, D Margolis, A B Troxel, J M Gelfand.   

Abstract

BACKGROUND: Psoriasis is a common disease frequently studied in large databases. To date the validity of psoriasis information has not been established in The Health Improvement Network (THIN).
OBJECTIVES: To investigate the validity of THIN for identifying patients with psoriasis and to determine if the database can be used to determine the natural history of the disease.
METHODS: First, we conducted a cross-sectional study to determine if psoriasis prevalence in THIN is similar to expected. Second, we created a cohort of 4900 patients, aged 45-64 years, with a psoriasis diagnostic Read Code and surveyed their general practitioners (GPs) to confirm the diagnosis clinically. Third, we created models to determine if psoriasis descriptors (extent, severity, duration and dermatologist confirmation) could be accurately captured from database records.
RESULTS: Psoriasis prevalence was 1·9%, and showed the characteristic age distribution expected. GP questionnaires were received for 4634 of 4900 cohort patients (95% response rate), and psoriasis diagnoses were confirmed in 90% of patients. Duration of disease in the database showed substantial agreement with physician query (κ = 0·69). GPs confirmed that the psoriasis diagnosis was corroborated by a dermatologist in 91% of patients whose database records contained a dermatology referral code associated with a psoriasis code. We achieved good discrimination between patients with and without extensive disease based on the number of psoriasis codes received per year (area under curve = 0·8).
CONCLUSIONS: THIN is a valid data resource for studying psoriasis and can be used to identify characteristics of the disease such as duration and confirmation by a dermatologist.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2011        PMID: 21073449      PMCID: PMC3064479          DOI: 10.1111/j.1365-2133.2010.10134.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  27 in total

1.  Assessing the validity of diagnostic information in administrative health care utilization data: experience in Saskatchewan.

Authors:  N S Rawson; C D'Arcy
Journal:  Pharmacoepidemiol Drug Saf       Date:  1998-11       Impact factor: 2.890

2.  Validation of death and suicide recording on the THIN UK primary care database.

Authors:  Gillian C Hall
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-02       Impact factor: 2.890

3.  Positive predictive value of computerized medical records for uncomplicated and complicated upper gastrointestinal ulcer.

Authors:  Andrea V Margulis; Luis A García Rodríguez; Sonia Hernández-Díaz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-10       Impact factor: 2.890

4.  Slopes of a receiver operating characteristic curve and likelihood ratios for a diagnostic test.

Authors:  B C Choi
Journal:  Am J Epidemiol       Date:  1998-12-01       Impact factor: 4.897

5.  Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.

Authors:  J Koo
Journal:  Dermatol Clin       Date:  1996-07       Impact factor: 3.478

6.  Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002.

Authors:  A B Kimball; D Robinson; Y Wu; C Guzzo; N Yeilding; C Paramore; K Fraeman; M Bala
Journal:  Dermatology       Date:  2008-03-18       Impact factor: 5.366

7.  Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis.

Authors:  Y B Brauchli; S S Jick; M Miret; C R Meier
Journal:  Br J Dermatol       Date:  2009-02-04       Impact factor: 9.302

8.  The risk of stroke in patients with psoriasis.

Authors:  Joel M Gelfand; Erica D Dommasch; Daniel B Shin; Rahat S Azfar; Shanu K Kurd; Xingmei Wang; Andrea B Troxel
Journal:  J Invest Dermatol       Date:  2009-05-21       Impact factor: 8.551

9.  The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.

Authors:  Shanu Kohli Kurd; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2008-11-20       Impact factor: 11.527

10.  The risk of mortality in patients with psoriasis: results from a population-based study.

Authors:  Joel M Gelfand; Andrea B Troxel; James D Lewis; Shanu Kohli Kurd; Daniel B Shin; Xingmei Wang; David J Margolis; Brian L Strom
Journal:  Arch Dermatol       Date:  2007-12
View more
  51 in total

1.  Response to 'Kidney disease in moderate-to-severe psoriasis: a critical appraisal'.

Authors:  J Wan; J M Gelfand
Journal:  Br J Dermatol       Date:  2016-02       Impact factor: 9.302

2.  Psoriasis and cardiovascular risk: strength in numbers, part II.

Authors:  Joel M Gelfand; Nehal N Mehta; Sinéad M Langan
Journal:  J Invest Dermatol       Date:  2011-05       Impact factor: 8.551

3.  Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study.

Authors:  Alexis Ogdie; Neilia Kay McGill; Daniel B Shin; Junko Takeshita; Thorvardur Jon Love; Megan H Noe; Zelma C Chiesa Fuxench; Hyon K Choi; Nehal N Mehta; Joel M Gelfand
Journal:  Eur Heart J       Date:  2018-10-14       Impact factor: 29.983

4.  The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study.

Authors:  Alexis Ogdie; Lauren Harter; Daniel Shin; Joshua Baker; Junko Takeshita; Hyon K Choi; Thorvardur Jon Love; Joel M Gelfand
Journal:  Ann Rheum Dis       Date:  2017-01-16       Impact factor: 19.103

5.  Psoriasis and the risk of diabetes: A prospective population-based cohort study.

Authors:  Marilyn T Wan; Daniel B Shin; Rebecca A Hubbard; Megan H Noe; Nehal N Mehta; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2017-11-08       Impact factor: 11.527

6.  Increased prevalence of HCV and hepatic decompensation in adults with psoriasis: a population-based study in the United Kingdom.

Authors:  M H Noe; S K Grewal; D B Shin; A Ogdie; J Takeshita; J M Gelfand
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-06-01       Impact factor: 6.166

7.  Prevalence and treatment patterns of psoriatic arthritis in the UK.

Authors:  Alexis Ogdie; Sinéad Langan; Thorvardur Love; Kevin Haynes; Daniel Shin; Nicole Seminara; Nehal N Mehta; Andrea Troxel; Hyon Choi; Joel M Gelfand
Journal:  Rheumatology (Oxford)       Date:  2012-12-07       Impact factor: 7.580

8.  The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study.

Authors:  Ada Man; Yanyan Zhu; Yuqing Zhang; Maureen Dubreuil; Young Hee Rho; Christine Peloquin; Robert W Simms; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2012-08-17       Impact factor: 19.103

9.  Risk of community-acquired pneumonia in patients with a diagnosis of pernicious anemia: a population-based retrospective cohort study.

Authors:  Christopher V Almario; David C Metz; Kevin Haynes; Yu-Xiao Yang
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-11       Impact factor: 2.566

10.  Validating the extract, transform, load process used to populate a large clinical research database.

Authors:  Michael J Denney; Dustin M Long; Matthew G Armistead; Jamie L Anderson; Baqiyyah N Conway
Journal:  Int J Med Inform       Date:  2016-07-29       Impact factor: 4.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.